Pleural Effusion, Malignant Clinical Trial
Official title:
Manometry vs Clinical Assessment in the Detection of Trapped Lung in Patients With Suspected Pleural Malignancy
Malignant pleural effusion is a common clinical problem with median survival of approximately 6 months thus efficient management of Malignant pleural effusion is important. In patients with a Trapped Lung, pleurodesis will be unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate detection of Trapped Lung prior to insertion would avoid futile attempts at talc pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan for an indwelling pleural catheter insertion.Pleural manometry allows direct and objective measurement of intra-pleural pressure during pleural fluid aspiration.The primary aim of this study is to determine whether the addition of digital pleural manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results in a clinically meaningful improvement in Trapped Lung detection.
Malignant pleural effusion is a common clinical problem with median survival of
approximately 6 months. Efficient management of Malignant pleural effusion is therefore a
major priority for patients, for whom failed procedures and the need for repeat hospital
admissions limits their time at home with family and friends.
The management of Malignant pleural effusion involves either complete pleural fluid drainage
followed by some form of pleurodesis or insertion of an indwelling pleural catheter.
Apposition of the parietal and visceral pleural surfaces is a pre-requisite for successful
pleurodesis. In patients with a non-expansile, or Trapped Lung, pleurodesis will be
unsuccessful and an indwelling pleural catheter should be inserted instead. Accurate
detection of Trapped Lung prior to insertion would avoid futile attempts at talc
pleurodesis, re-intervention following failed pleurodesis and allow adequate time to plan
for an indwelling pleural catheter insertion, including training of the patient's District
Nurses. Clinical judgment is currently used to detect Trapped Lung. This involves review of
available imaging and direct visualisation of the surface of the lung during local
anaesthetic thoracoscopy. Unfortunately, recent data suggest this is frequently inaccurate,
with 30% and 13% of cases of Trapped Lung correctly identified in recent local and national
audit data respectively.
Pleural manometry allows direct and objective measurement of intra-pleural pressure during
pleural fluid aspiration. Pleural pressure measurements can also be used to compute Pleural
Elastance, defined as change in pleural pressure divided by change in pleural volume.
Previous studies have shown that a rapid and sustained drop in intra-pleural pressure during
fluid aspiration can predict Trapped Lung but these data have not been prospectively
compared with current clinical practice.
The primary aim of this study is to determine whether the addition of digital pleural
manometry to clinical judgment, prior to and during local anaesthetic thoracoscopy, results
in a clinically meaningful improvement in Trapped Lung detection. Digital pleural manometry
will be recorded using a Conformité Européene marked (CE-marked) device used within its
existing clinical indication (developed in conjunction with our commercial partner Rocket
Medical plc).
65 Subjects will have a single study visit, which will coincide with their planned clinical
admission for local anaesthetic thoracoscopy. Subjects will exit the study after a follow-up
clinic visit 3 months after the date of local anaesthetic thoracoscopy. A study-specific
volumetric Magnetic Resonance Imaging scan of the pleural cavity will be performed as per
pre-defined imaging protocols.
The study will be performed at a single centre: Queen Elizabeth University Hospital,
Glasgow.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05693727 -
Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate Dehydrogenase, interferonY, Tumor Necrosis Factor,and Interleukins{2,12,18}for Differentiation Between Malignant and Non Malignant Pleural Effusion
|
||
Recruiting |
NCT05910112 -
Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
|
||
Completed |
NCT03270215 -
The Added Value of CT Scanning in Patients With an Unilateral Pleural Effusion
|
||
Completed |
NCT03272997 -
The Value of PET-CT in Pleural Effusions
|
||
Completed |
NCT00099541 -
Non-small Cell Lung Cancer Registry
|
Phase 4 | |
Recruiting |
NCT04844827 -
Pleural Carcinomatosis Tissue Banking
|
||
Not yet recruiting |
NCT06436807 -
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
|
||
Recruiting |
NCT05278975 -
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
|
Phase 1/Phase 2 | |
Recruiting |
NCT02407912 -
Cisplatin for Malignant Pleural Effusion in Patients With Non-small-cell Lung Cancer
|
N/A | |
Terminated |
NCT00316134 -
Multiple Biomarkers in Undiagnosed Pleural Effusion
|
N/A | |
Not yet recruiting |
NCT06275178 -
Medical Thoracoscopy for Diagnosing Unexplained Pleural Effusion: a National Multicenter Retrospective Study
|
||
Recruiting |
NCT04684459 -
Dual-targeting HER2 and PD-L1 CAR-T for Cancers With Pleural or Peritoneal Metastasis
|
Early Phase 1 | |
Recruiting |
NCT04670562 -
Longitudinal Follow up of Patients With Pleural Effusion
|
||
Completed |
NCT03276715 -
Prognostic Factors on Malignant Pleural Effusion
|
||
Completed |
NCT03394105 -
Intrapleural Docetaxel Administration Using Medical Pleuroscopy in Malignant Effusion With Lung Cancer
|
Phase 2 | |
Recruiting |
NCT05461430 -
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
|
||
Terminated |
NCT02702700 -
Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
|
Phase 1 | |
Recruiting |
NCT02045121 -
Multicentre Study Comparing Indwelling Pleural Catheter With Talc Pleurodesis for Malignant Pleural Effusion Management
|
N/A | |
Completed |
NCT01670786 -
Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion
|
Phase 4 | |
Active, not recruiting |
NCT05077111 -
A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia
|
Phase 4 |